Related Experiment Video
Updated: May 15, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Advances in the management of skin cancer
Pamela D Martin1, David J Argyle
1Royal (Dick) School of Veterinary Studies and Roslin Institute, Easter Bush, Midlothian EH25 9RG, UK.
Abstract:
Skin cancer is one of the most commonly diagnosed cancers in the world today in both humans and our pet population. Advances in molecular techniques are now affording us an opportunity to develop therapeutics targeted at specific cancer-related cellular pathways. However, despite progress in conventional treatments, such as chemotherapy and radiation, and the new targeted therapies, some cancers, such as melanoma and cutaneous lymphoma, continue to cause significant mortality and morbidity. This short synopsis is not complete but is aimed at providing an insight into current advanced treatments and horizon therapies for cutaneous malignancies in dogs and cats with comparative aspects.
Insights
This study reviews advanced treatments for skin cancer in pets. It highlights new targeted therapies and future treatments for canine and feline skin malignancies.
Area of Science:
- Veterinary Oncology
- Comparative Medicine
- Dermatology
Background:
- Skin cancer is a prevalent diagnosis in both human and animal populations.
- Conventional treatments like chemotherapy and radiation have limitations for certain skin cancers.
- Melanoma and cutaneous lymphoma remain significant causes of morbidity and mortality in pets.
Purpose of the Study:
- To provide an overview of current advanced therapeutic strategies for canine and feline cutaneous malignancies.
- To explore emerging and horizon therapies for pet skin cancers.
- To discuss comparative aspects of skin cancer treatment between species.
Main Methods:
- Review of current literature on advanced treatments for skin cancer in dogs and cats.
- Analysis of molecular techniques for targeted cancer therapies.
- Comparative assessment of treatment efficacy and outcomes.
Main Results:
- Molecular advances offer potential for targeted therapeutics.
- Despite progress, challenges remain in treating aggressive skin cancers like melanoma and lymphoma.
- Comparative insights can inform future treatment development.
Conclusions:
- Advanced and targeted therapies show promise for treating pet skin cancers.
- Further research into novel treatments and comparative oncology is crucial.
- Addressing mortality and morbidity from skin malignancies in pets requires ongoing innovation.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
